[
  {
    "ts": null,
    "headline": "Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy According to Hedge Funds?",
    "summary": "We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other best pharma stocks to buy according to hedge funds. Why is China the Talk of the Town in […]",
    "url": "https://finnhub.io/api/news?id=ff137da27c546fd65498a79c26141e7d50eef0085a04d43e8ba11b0260710f6d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741804361,
      "headline": "Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy According to Hedge Funds?",
      "id": 133185679,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other best pharma stocks to buy according to hedge funds. Why is China the Talk of the Town in […]",
      "url": "https://finnhub.io/api/news?id=ff137da27c546fd65498a79c26141e7d50eef0085a04d43e8ba11b0260710f6d"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb Company (BMY) Presents at Leerink Partners 2025 Global Healthcare Conference (Transcript)",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) Leerink Partners 2025 Global Healthcare Conference Call March 12, 2025 11:20 AM ETCompany ParticipantsRoland Chen -...",
    "url": "https://finnhub.io/api/news?id=16537f53c01ff140c9c892991fe17c2add307763e3c968d81fd482360af83b51",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741801564,
      "headline": "Bristol-Myers Squibb Company (BMY) Presents at Leerink Partners 2025 Global Healthcare Conference (Transcript)",
      "id": 133159076,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) Leerink Partners 2025 Global Healthcare Conference Call March 12, 2025 11:20 AM ETCompany ParticipantsRoland Chen -...",
      "url": "https://finnhub.io/api/news?id=16537f53c01ff140c9c892991fe17c2add307763e3c968d81fd482360af83b51"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors",
    "summary": "Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=e1936f1cca57aa04ac2b3551291c48fbc1c8951ea229efa2ec56bb48356d30d7",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741797420,
      "headline": "Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors",
      "id": 133173226,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=e1936f1cca57aa04ac2b3551291c48fbc1c8951ea229efa2ec56bb48356d30d7"
    }
  },
  {
    "ts": null,
    "headline": "Caterpillar: Diversification Without Diworsification; Home Depot Looks Healthy, So Do Others",
    "summary": "Diversify Caterpillar holdings with tax-efficient strategies. Explore HD, LOW, and SNA for income replacement potential and strong dividend growth.",
    "url": "https://finnhub.io/api/news?id=9cf9ca56103d930886a81f4fb47de06448e6f9ac30502d33ccf692493d220c13",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741786147,
      "headline": "Caterpillar: Diversification Without Diworsification; Home Depot Looks Healthy, So Do Others",
      "id": 133156626,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2033001899/image_2033001899.jpg?io=getty-c-w750",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Diversify Caterpillar holdings with tax-efficient strategies. Explore HD, LOW, and SNA for income replacement potential and strong dividend growth.",
      "url": "https://finnhub.io/api/news?id=9cf9ca56103d930886a81f4fb47de06448e6f9ac30502d33ccf692493d220c13"
    }
  },
  {
    "ts": null,
    "headline": "Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know",
    "summary": "Bristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=07a42981f9ec6dcfc3d894dd2cdcb4cba3625de4b21ea1cc777af83d74137742",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741784414,
      "headline": "Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know",
      "id": 133185680,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=07a42981f9ec6dcfc3d894dd2cdcb4cba3625de4b21ea1cc777af83d74137742"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb To Acquire 2seventy bio - A Sad But Inevitable End To A Cell Therapy Pioneer",
    "summary": "Bristol-Myers Squibb acquires 2seventy bio for $286M, marking the end of a once-promising biotech. Check out if this is a good deal for BMY or TSVT.",
    "url": "https://finnhub.io/api/news?id=03a447d1e0aa2206572e9eaca13d73dbd41253613c26a94849af54db0de04941",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741782139,
      "headline": "Bristol-Myers Squibb To Acquire 2seventy bio - A Sad But Inevitable End To A Cell Therapy Pioneer",
      "id": 133153846,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1447432962/image_1447432962.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Bristol-Myers Squibb acquires 2seventy bio for $286M, marking the end of a once-promising biotech. Check out if this is a good deal for BMY or TSVT.",
      "url": "https://finnhub.io/api/news?id=03a447d1e0aa2206572e9eaca13d73dbd41253613c26a94849af54db0de04941"
    }
  },
  {
    "ts": null,
    "headline": "Fidelity Select Health Care Portfolio Q4 2024 Review",
    "summary": "Health care stocks returned -9.75% in the final quarter of 2024, according to the MSCI U.S. IMI Health Care 25/50 Index, widely lagging the 2.41% gain of the broad-based S&P 500Â® index.",
    "url": "https://finnhub.io/api/news?id=0d949fbfb9bc6d781dd942fc4d702b6a460558e2a5372e95abd05eb5e16657ae",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741773660,
      "headline": "Fidelity Select Health Care Portfolio Q4 2024 Review",
      "id": 133149109,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/183355336/image_183355336.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Health care stocks returned -9.75% in the final quarter of 2024, according to the MSCI U.S. IMI Health Care 25/50 Index, widely lagging the 2.41% gain of the broad-based S&P 500Â® index.",
      "url": "https://finnhub.io/api/news?id=0d949fbfb9bc6d781dd942fc4d702b6a460558e2a5372e95abd05eb5e16657ae"
    }
  }
]